Literature DB >> 21246261

Malignant transformation of 293 cells induced by ectopic expression of human Nanog.

Yan-Li Lin1, Zheng-Bin Han, Fu-Yin Xiong, Li-Yuan Tian, Xiao-Jie Wu, Shi-Wei Xue, Yan-Rong Zhou, Ji-Xian Deng, Hong-Xing Chen.   

Abstract

Tumor development has long been known to resemble abnormal embryogenesis. The ESC self-renewal gene NANOG is purportedly expressed in some epithelial cancer cells and solid tumors, but a casual role in tumor development has remained unclear. In order to more comprehensively elucidate the relationship between human Nanog and tumorigenesis, the hNanog was ectopically expressed in the 293 cell line to investigate its potential for malignant transformation of cells both in vitro and in vivo. Here we provide compelling evidence that the overexpression of hNanog resulted in increased cell proliferation, anchor-independent growth in soft agar, and formation of tumors after subcutaneous injection of athymic nude mice. Pathologic analysis revealed that these tumors were poorly differentiated. In analysis of the underlying molecular mechanism, two proteins, FAK and Ezrin, were identified to be upregulated in the hNanog expressing 293 cells. Our results demonstrate that hNanog is a potent human oncogene and has the ability to induce cellular transformation of human cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246261     DOI: 10.1007/s11010-011-0717-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

2.  Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

Authors:  Travis Young; Fang Mei; Jinsong Liu; Robert C Bast; Alexander Kurosky; Xiaodong Cheng
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

3.  Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells.

Authors:  Tong Ming Liu; Ying Nan Wu; Xi Min Guo; James Hoi Po Hui; Eng Hin Lee; Bing Lim
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

Review 4.  Role of focal adhesion kinase in integrin signaling.

Authors:  J L Guan
Journal:  Int J Biochem Cell Biol       Date:  1997 Aug-Sep       Impact factor: 5.085

5.  Expression of focal adhesion kinase gene and invasive cancer.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

Review 6.  Serial analysis of gene expression and cancer.

Authors:  Heiko Hermeking
Journal:  Curr Opin Oncol       Date:  2003-01       Impact factor: 3.645

7.  Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.

Authors:  Travis W Young; Fang C Mei; Gong Yang; Jennifer A Thompson-Lanza; Jinsong Liu; Xiaodong Cheng
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

8.  Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase.

Authors:  L Kornberg; H S Earp; J T Parsons; M Schaller; R L Juliano
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

9.  Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.

Authors:  Michelle K Y Siu; Esther S Y Wong; Hoi Yan Chan; Hextan Y S Ngan; Kelvin Y K Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

10.  Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.

Authors:  K Burridge; C E Turner; L H Romer
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  15 in total

1.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 2.  Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Authors:  Collene R Jeter; Tao Yang; Junchen Wang; Hsueh-Ping Chao; Dean G Tang
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

3.  Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.

Authors:  J Kim; Y Liu; M Qiu; Y Xu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

Review 4.  Targeting FAK in human cancer: from finding to first clinical trials.

Authors:  Vita M Golubovskaya
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

5.  Immortalized cells and one oncogene in malignant transformation: old insights on new explanation.

Authors:  Vadym M Kavsan; Anton V Iershov; Olena V Balynska
Journal:  BMC Cell Biol       Date:  2011-05-23       Impact factor: 4.241

6.  Transfer of malignant trait to immortalized human cells following exposure to human cancer serum.

Authors:  Mohamed Abdouh; Shufeng Zhou; Vincenzo Arena; Manuel Arena; Anthoula Lazaris; Ronald Onerheim; Peter Metrakos; Goffredo Orazio Arena
Journal:  J Exp Clin Cancer Res       Date:  2014-09-30

7.  Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.

Authors:  Caroline Schreiber; Vanessa Kuch; Viktor Umansky; Jonathan P Sleeman
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.

Authors:  Ling-Ling Sun; Jian-Yi Wu; Zhi-Yong Wu; Jin-Hui Shen; Xiu-E Xu; Bo Chen; Shao-Hong Wang; En-Min Li; Li-Yan Xu
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396

Review 9.  Targeting cancer stem cells: emerging role of Nanog transcription factor.

Authors:  Mong-Lien Wang; Shih-Hwa Chiou; Cheng-Wen Wu
Journal:  Onco Targets Ther       Date:  2013-09-04       Impact factor: 4.147

10.  The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells.

Authors:  Almudena Bosch; Konstantina Panoutsopoulou; Josep Maria Corominas; Ramón Gimeno; Gema Moreno-Bueno; Juan Martín-Caballero; Saleta Morales; Tania Lobato; Carles Martínez-Romero; Eduardo F Farias; Xavier Mayol; Amparo Cano; Inmaculada Hernández-Muñoz
Journal:  Oncotarget       Date:  2014-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.